Design and validation of a cross-cultural virtual exchange experience among bilingual medical students.

Exposure to cross-cultural medical education is essential for professionals aiming to work in global health or serve diverse communities. However, traditional in-person exchange programs can be complex, costly, and restricted, particularly during times when travel is limited, such as during the COVID-19 pandemic. These challenges prompted us to explore novel approaches to support cross-cultural exchange programs.

Cardiovascular Safety in Oncology Clinical Trials: JACC: CardioOncology Primer.

The development of novel treatments has improved cancer outcomes but may result in cardiovascular toxicities. Traditional approaches to clinical trial safety evaluation have limitations in their ability to detect signals of cardiovascular risk. Mechanisms to increase power and specificity to clarify cardiovascular safety are required.

Comparative Analysis of Influenza Epidemiology Before and After the COVID-19 Pandemic in Argentina (2018-2019 vs. 2022-2023).

Introduction: The COVID-19 pandemic altered the epidemiology of respiratory viruses other than SARS-CoV-2. This study investigated the clinical-epidemiological pattern of hospitalized pediatric patients with acute lower respiratory tract infections (ALRI) and influenza in Argentina, comparing prepandemic and postpandemic periods.

Materials And Methods: This multicenter, cross-sectional study included patients under 18 years old admitted for ALRIs in five tertiary centers of Argentina before (2018 and 2019) and after (2022 and 2023) COVID-19.

Respiratory Syncytial Virus Epidemiology in Argentina: From COVID-19 Pandemic to the Maternal Immunization Strategy.

Introduction: Worldwide, respiratory syncytial virus (RSV) is the leading cause of acute lower respiratory tract infections (LRTIs) and hospital admissions among infants and young children. The COVID-19 pandemic changed the epidemiology and clinical patterns of respiratory viruses other than severe acute respiratory syndrome coronavirus 2. Argentina introduced the RSV maternal vaccine in 2024.